These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 25597706

  • 1. Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels.
    Ase AR, Honson NS, Zaghdane H, Pfeifer TA, Séguéla P.
    Mol Pharmacol; 2015 Apr; 87(4):606-16. PubMed ID: 25597706
    [Abstract] [Full Text] [Related]

  • 2. Carbamazepine derivatives with P2X4 receptor-blocking activity.
    Tian M, Abdelrahman A, Weinhausen S, Hinz S, Weyer S, Dosa S, El-Tayeb A, Müller CE.
    Bioorg Med Chem; 2014 Feb 01; 22(3):1077-88. PubMed ID: 24411477
    [Abstract] [Full Text] [Related]

  • 3. P2X4 subunits are part of P2X native channels in murine myenteric neurons.
    Nieto-Pescador MG, Guerrero-Alba R, Valdez-Morales E, Espinosa-Luna R, Jiménez-Vargas N, Liñan-Rico Andrómeda A, Ramos-Lomas TL, Díaz-Hernández Verónica V, Montaño LM, Barajas-López C.
    Eur J Pharmacol; 2013 Jun 05; 709(1-3):93-102. PubMed ID: 23567069
    [Abstract] [Full Text] [Related]

  • 4. An Allosteric Inhibitory Site Conserved in the Ectodomain of P2X Receptor Channels.
    Ase AR, Therrien É, Séguéla P.
    Front Cell Neurosci; 2019 Jun 05; 13():121. PubMed ID: 31024257
    [Abstract] [Full Text] [Related]

  • 5. P2X4 Receptor-Dependent Ca2+ Influx in Model Human Monocytes and Macrophages.
    Layhadi JA, Fountain SJ.
    Int J Mol Sci; 2017 Oct 27; 18(11):. PubMed ID: 29077063
    [Abstract] [Full Text] [Related]

  • 6. Identification of the molecular determinants of antagonist potency in the allosteric binding pocket of human P2X4.
    Pasqualetto G, Zuanon M, Brancale A, Young MT.
    Front Pharmacol; 2023 Oct 27; 14():1101023. PubMed ID: 36843952
    [Abstract] [Full Text] [Related]

  • 7. ATP Evokes Ca2+ Responses and CXCL5 Secretion via P2X4 Receptor Activation in Human Monocyte-Derived Macrophages.
    Layhadi JA, Turner J, Crossman D, Fountain SJ.
    J Immunol; 2018 Feb 01; 200(3):1159-1168. PubMed ID: 29255078
    [Abstract] [Full Text] [Related]

  • 8. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.
    Obrecht AS, Urban N, Schaefer M, Röse A, Kless A, Meents JE, Lampert A, Abdelrahman A, Müller CE, Schmalzing G, Hausmann R.
    Neuropharmacology; 2019 Nov 01; 158():107749. PubMed ID: 31461640
    [Abstract] [Full Text] [Related]

  • 9. Investigation of the inhibitory effects of the benzodiazepine derivative, 5-BDBD on P2X4 purinergic receptors by two complementary methods.
    Balázs B, Dankó T, Kovács G, Köles L, Hediger MA, Zsembery A.
    Cell Physiol Biochem; 2013 Nov 01; 32(1):11-24. PubMed ID: 23867750
    [Abstract] [Full Text] [Related]

  • 10. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor.
    Hempel C, Nörenberg W, Sobottka H, Urban N, Nicke A, Fischer W, Schaefer M.
    Neuropharmacology; 2013 Dec 01; 75():365-79. PubMed ID: 23954492
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Extracellular binding sites of positive and negative allosteric P2X4 receptor modulators.
    Weinhausen S, Nagel J, Namasivayam V, Spanier C, Abdelrahman A, Hanck T, Hausmann R, Müller CE.
    Life Sci; 2022 Dec 15; 311(Pt A):121143. PubMed ID: 36328074
    [Abstract] [Full Text] [Related]

  • 13. Structural insights into the allosteric inhibition of P2X4 receptors.
    Shen C, Zhang Y, Cui W, Zhao Y, Sheng D, Teng X, Shao M, Ichikawa M, Wang J, Hattori M.
    Nat Commun; 2023 Oct 13; 14(1):6437. PubMed ID: 37833294
    [Abstract] [Full Text] [Related]

  • 14. Lithocholic acid inhibits P2X2 and potentiates P2X4 receptor channel gating.
    Sivcev S, Slavikova B, Ivetic M, Knezu M, Kudova E, Zemkova H.
    J Steroid Biochem Mol Biol; 2020 Sep 13; 202():105725. PubMed ID: 32652201
    [Abstract] [Full Text] [Related]

  • 15. Lidocaine preferentially inhibits the function of purinergic P2X7 receptors expressed in Xenopus oocytes.
    Okura D, Horishita T, Ueno S, Yanagihara N, Sudo Y, Uezono Y, Minami T, Kawasaki T, Sata T.
    Anesth Analg; 2015 Mar 13; 120(3):597-605. PubMed ID: 25695577
    [Abstract] [Full Text] [Related]

  • 16. Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors.
    Bidula S, Nadzirin IB, Cominetti M, Hickey H, Cullum SA, Searcey M, Schmid R, Fountain SJ.
    Mol Pharmacol; 2022 Jan 13; 101(1):33-44. PubMed ID: 34718224
    [Abstract] [Full Text] [Related]

  • 17. Tanshinone II A sulfonate, but not tanshinone II A, acts as potent negative allosteric modulator of the human purinergic receptor P2X7.
    Kaiser M, Sobottka H, Fischer W, Schaefer M, Nörenberg W.
    J Pharmacol Exp Ther; 2014 Sep 13; 350(3):531-42. PubMed ID: 24970925
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of P2X4 function by P2Y6 UDP receptors in microglia.
    Bernier LP, Ase AR, Boué-Grabot É, Séguéla P.
    Glia; 2013 Dec 13; 61(12):2038-49. PubMed ID: 24123515
    [Abstract] [Full Text] [Related]

  • 20. Purinergic P2X receptors: structural models and analysis of ligand-target interaction.
    Dal Ben D, Buccioni M, Lambertucci C, Marucci G, Thomas A, Volpini R.
    Eur J Med Chem; 2015 Jan 07; 89():561-80. PubMed ID: 25462266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.